(Q46310916)

21 December 2017

title

Should prednisolone be first-line therapy for acute gout? (English)

1 reference

21 December 2017

author name string

Pascal Richette

series ordinal

1

1 reference

21 December 2017

Thomas Bardin

series ordinal

2

1 reference

21 December 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

372

1 reference

21 December 2017

issue

9646

1 reference

21 December 2017

page(s)

1301; author reply 1301-2

1 reference

21 December 2017

Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961548-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961548-2

1 reference

7 January 2021

Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961548-2

7 January 2021

EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961548-2

7 January 2021

Colchicine in acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2808%2961548-2

7 January 2021

10.1016/S0140-6736(08)61548-2

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017